Tata Chemicals (TATACHEM) Q2 24/25 earnings summary

Executive summary

• Q2 FY25 consolidated revenue rose 6% sequentially to ₹3,999 crore, with EBITDA up 8% to ₹618 crore and PAT up 53% to ₹267 crore, though H1 FY25 saw revenue down 5% year-over-year and PAT down 54%.

• Indian operations faced heavy rain disruptions but have stabilized, with all major expansion capacities in India commissioned and fully ramped up.

• U.S. operations delivered robust volumes and margins, while the U.K. segment faced challenges due to negative spark spreads and asset impairment, but is expected to recover by Q3.

• Kenya and Rallis segments reported higher volumes and strong domestic growth, respectively.

• Net debt increased year-over-year, standing at ₹5,190 crore, mainly due to lower EBITDA, higher working capital, and lease capitalization.

Financial highlights

• Q2 FY25 consolidated revenue: ₹3,999 crore (up 6% sequentially); EBITDA: ₹618 crore (up 8%); PAT: ₹267 crore (up 53%).

• Operating margin for Q2 FY25 was 8.53%, up from Q1 but down from Q2 FY24; EBITDA margin was 15% (consolidated).

• Indian EBITDA was impacted by INR 40 crore due to weather-related inefficiencies, with INR 25 crore from unstable operations and INR 15 crore as an insurance claim.

• Net debt as of Sep 2024: ₹5,190 crore; gross debt: ₹6,479 crore.

• No significant maturities are due in the current year; most are scheduled for 2026-2027.

Outlook and guidance

• Operations in India have stabilized, and full utilization of new capacities is expected in H2 FY25.

• Management expects margin recovery in India, with most cost increases to be reversed except for a minor portion.

• U.S. and Kenya capacity expansions are on track, with 400,000 tons in the U.S. and 300,000 tons in Kenya to be added over 30-36 months.

• Silica business expansion to 60,000 tons is planned, targeting INR 500 crore in revenue within 2-3 years.

• Focus on value-added products, capacity expansions, and sustainability initiatives across geographies.